Home » Stocks » SYK

Stryker Corporation (SYK)

Stock Price: $232.81 USD -0.91 (-0.39%)
Updated November 27, 1:03 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 87.49B
Revenue (ttm) 14.22B
Net Income (ttm) 1.76B
Shares Out 375.79M
EPS (ttm) 4.61
PE Ratio 50.50
Forward PE 25.91
Dividend $2.30
Dividend Yield 0.99%

Stock Quote

Trading Day November 27
Last Price $232.81
Previous Close $233.72
Change ($) -0.91
Change (%) -0.39%
Day's Open 236.17
Day's Range 231.81 - 236.60
Day's Volume 787,609
52-Week Range 124.54 - 242.51

More Stats

Market Cap 87.49B
Enterprise Value 93.45B
Earnings Date (est) Feb 2, 2021
Ex-Dividend Date Sep 29, 2020
Shares Outstanding 375.79M
Float 347.79M
EPS (basic) 4.70
EPS (diluted) 4.61
FCF / Share 6.00
Dividend $2.30
Dividend Yield 0.99%
Earnings Yield 1.98%
FCF Yield 2.58%
Payout Ratio 48.90%
Shares Short 3.15M
Short Ratio 2.81
Short % of Float 0.91%
Beta 0.84
PE Ratio 50.50
Forward PE 25.91
P/FCF Ratio 38.81
PS Ratio 6.15
PB Ratio 6.74
Revenue 14.22B
Operating Income 2.42B
Net Income 1.76B
Free Cash Flow 2.25B
Net Cash -5.97B
Net Cash / Share -15.88
Gross Margin 68.92%
Operating Margin 17.00%
Profit Margin 12.30%
FCF Margin 15.85%
ROA 6.52%
ROE 13.88%
ROIC 11.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (28)

Buy 14
Overweight 2
Hold 11
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$227.67*
(-2.21% downside)
Low
194
Current: $232.81
High
258
Target: 227.67
*Average 12-month price target from 24 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue14,88413,60112,44411,3259,9469,6759,0218,6578,3077,320
Revenue Growth9.43%9.3%9.88%13.86%2.8%7.25%4.2%4.21%13.48%-
Gross Profit9,6968,9388,1807,5046,6026,3566,0195,8765,4965,034
Operating Income2,7132,5372,2972,1751,8611,2461,2561,7411,6861,751
Net Income2,0833,5531,0201,6471,4395151,0061,2981,3451,273
Shares Outstanding374374374374377379379381387396
Earnings Per Share5.489.342.684.353.781.342.633.393.453.19
EPS Growth-41.33%248.51%-38.39%15.08%182.09%-49.05%-22.42%-1.74%8.15%-
Dividend Per Share2.141.931.751.571.421.261.100.900.750.63
Dividend Growth10.62%10.6%11.5%10.6%12.3%14.55%21.82%20.08%19.37%-
Operating Cash Flow2,1912,6101,5591,9159811,7821,8861,6571,4341,547
Capital Expenditures-649-572-598-490-270-233-195-210-159-121
Free Cash Flow1,5422,0389611,4257111,5491,6911,4471,2751,426
Cash & Equivalents4,4253,6992,7933,3844,0795,0003,9804,2853,4184,380
Total Debt11,0909,8597,2226,9143,9983,9732,7641,7621,7681,021
Net Cash / Debt-6,665-6,160-4,429-3,53081.001,0271,2162,5231,6503,359
Assets30,16727,22922,19720,43516,22317,27915,74313,20612,14610,895
Liabilities17,36015,49912,21710,8857,7128,6846,6964,6094,4633,721
Book Value12,80711,7309,9669,5508,5118,5959,0478,5977,6837,174
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Stryker Corporation
Country United States
Employees 40,000
CEO Kevin A. Lobo

Stock Information

Ticker Symbol SYK
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: SYK

Description

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.